Search results
AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid...
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo (OTC: DSNKY) reported high-level results from an...
On an Immunotherapy Drug? Acetaminophen Makes It Less Effective, Research Says
Woman's World via Yahoo News· 1 year agoIf you or a loved one has cancer, you know by now that anti-cancer drugs are hard on the body. They...
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment...
Benzinga via Yahoo Finance· 12 months agoThe FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used...
Pfizer's Cancer Drug Partner Mulls Sale: Report
Benzinga via Yahoo Finance· 2 years agoBloomberg reports that Pfizer Inc's (NYSE: PFE) cancer drug partner CStone Pharmaceuticals (OTC: CSPHF) in China is considering strategic options,...
Birth control pill Opill may soon be available over the counter. Here’s what you need to know.
Yahoo Life Style via AOL· 1 year agoIf approved, the birth control pill Opill would be available just like any other over the counter...
Postmenopausal Bleeding: When Are Symptoms Concerning?
Verywell Health via Yahoo News· 6 months agoBleeding sometimes, but not always, suggests endometrial cancer Medically reviewed by Renita White,...
AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) reported topline data from the DESTINY-Breast02 phase 3 trial of...
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Benzinga via Yahoo Finance· 1 year agoGermany’s Merck KGaA (OTC: MKGAF) (OTC: MKKGY) has regained exclusive worldwide rights to develop,...
Common Medications for Lower Back Pain Relief
Verywell Health via Yahoo News· 4 months agoMedications, including over-the-counter (OTC) and prescription drugs, are available to manage pain and provide relief. This article will discuss common...
3 Growth Stocks Poised for Huge Gains in 2023
Motley Fool· 1 year agoPharmaceutical companies Bayer (OTC: BAYR.Y), Eli Lilly (NYSE: LLY), and AstraZeneca (NASDAQ: AZN) had big years last year, bucking the rest of the...
